Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Jacobs' (JEC) CH2M Buyout Approved By CH2M Shareholders

Published 12/14/2017, 08:26 PM
Updated 07/09/2023, 06:31 AM

Jacobs Engineering Group Inc. (NYSE:JEC) and CH2M HILL Companies, Ltd. announced on Dec 13, that approximately 95.6% of CH2M HILL’s stockholders have approved the acquisition of CH2M HILL by Jacobs. The deal will be executed through a reverse subsidiary merger.

This deal was originally announced on Aug 2.

Update on the Acquisition Deal: Preliminary Results

In addition, the companies gave preliminary results of the merger consideration election held on the date. CH2M HILL’s stockholders, of record as on Dec 15, 2017, were to choose one of the three consideration options as their preferred mode of payment in exchange of each share held by them. The options included the Mixed Election Consideration — cash of $52.85 and 0.6677 of Jacob’s shares, the Cash Election Consideration — cash of $88.08, and the Stock Election Consideration — 1.6693 of Jacob’s shares.

As noted, shareholders holding approximately 9.3% of CH2M HILLS shares voted for the Mixed Election Consideration, 21.5% for the Cash Election Consideration and 66.8% for the Stock Election Consideration. Also, shareholders of roughly 2.4% shares did not make valid election and were considered to have chosen the Mixed Election Consideration. Based on these preliminary results, proration is likely be applied to the shareholders opting for the Stock Election Consideration.

What CH2M Buyout Means for Jacobs?

Per the agreement signed in August, Jacobs’ acquisition of CH2M HILLS will cost the company approximately $2.85 billion, of which roughly 60% will be paid in cash and the rest 40% in the form of shares. Upon completion of the transaction, CH2M HILLS shareholders will hold approximately 15% of Jacobs’ shares. As regard to the cash portion, Jacobs intends to finance $2.4 billion cash through cash on hand, existing revolving credit facility and new debt arrangements.

The acquisition will make Jacobs a premier $15 billion global solutions provider. It will widen the company’s product offerings to existing and new clients while will gain easy access to unexplored markets.

The company anticipates annual cost savings of $150 million by the end of the second year following the deal closure while related one-time costs are likely to amount to $225 million. By the end of the first year following the deal completion, the company anticipates the acquired assets to boost its adjusted cash earnings per share by 25% and earnings per share by 15%.

In the last three months, Jacob’s shares have yielded roughly 16.5% return, outperforming 11.2% gain of the industry it belongs to.



Zacks Rank and Key Picks

With approximately $8 billion market capitalization, Jacobs currently carries a Zacks Rank #3 (Hold). In the last 60 days, earnings estimates for the stock remained stable for both fiscal 2018 and fiscal 2019 at $3.44 and $3.82, respectively.

Jacobs Engineering Group Inc. Price and Consensus

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Jacobs Engineering Group Inc. Price and Consensus | Jacobs Engineering Group Inc. Quote

Better-ranked stocks in Zacks Construction sector include Universal Forest Products Inc. (NASDAQ:UFPI) , KBR, Inc. (NYSE:KBR) and Willdan Group, Inc. (NASDAQ:WLDN) . While Universal Forest sports a Zacks Rank #1 (Strong Buy), both KBR, Inc. and Willdan Group carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Universal Forest’s financial performance was impressive, with a positive earnings surprise of 14.69% in the last quarter. Also, earnings estimates for 2017 and 2018 were revised upward over the last 60 days.

KBR delivered a positive earnings surprise of 16.67% in the last quarter. Also, earnings estimates for 2017 and 2018 were revised upward in the last 60 days.

Willdan Group delivered an average positive earnings surprise of 44.80% in the trailing four quarters. Also, bottom-line expectations for 2017 and 2018 improved over the past 60 days.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



Universal Forest Products, Inc. (UFPI): Free Stock Analysis Report

Jacobs Engineering Group Inc. (JEC): Free Stock Analysis Report

KBR, Inc. (KBR): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Willdan Group, Inc. (WLDN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.